Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
94 Additionally, improvements were noted in body weight, quality of life, and functional capacity
Watch for mild GI side effects (nausea, constipation) during extended studies
However, during the weight loss process, lean body mass (including muscle) shows heterogeneity of increase, decrease, and remain unchanged in different clinical studies
Medication has given me my life back
Survodutide (BI-456906) is an investigational dual agonist targeting: GLP-1 receptors , which regulate appetite, gastric emptying, and glucose metabolism Glucagon receptors , which influence energy expenditure, fat oxidation, and hepatic metabolism Unlike GLP-1only therapies, survodutide is designed to influence both intake and metabolic output
US$ 25.33
US$ 26.99
US$ 23.67
US$ 22.38
